(Q45403802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Vincenzo Baldo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

V Baldo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A Floreani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

E Fragapane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

R Trivello

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

21 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

542-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17514499%20AND%20SRC:MED&resulttype=core&format=json

Vaccines and antiviral drugs in pandemic preparedness

30 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-007-9100-4

The immunogenicity of influenza virus vaccine in solid organ transplant recipients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-007-9100-4

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

21 January 2018

1 reference

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

12 December 2020

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

12 December 2020

Effectiveness of influenza vaccine in health care professionals: a randomized trial

1 reference

12 December 2020

Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season

1 reference

12 December 2020

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

12 December 2020

Strategies for containing a global influenza pandemic.

1 reference

12 December 2020

MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications

1 reference

12 December 2020

1 reference

12 December 2020

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

12 December 2020

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Comparison of three different influenza vaccines in institutionalised elderly

1 reference

12 December 2020

1 reference

12 December 2020

Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers

1 reference

12 December 2020

Antibody response to influenza vaccination in the elderly: a quantitative review

1 reference

12 December 2020

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

1 reference

12 December 2020

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

1 reference

12 December 2020

Epidemiology and virology of influenza illness. Based on a presentation by Arnold S. Monto, MD

1 reference

12 December 2020

Epidemiology and pathogenesis of influenza

1 reference

12 December 2020

The epidemiology and clinical impact of pandemic influenza.

1 reference

12 December 2020

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

1 reference

12 December 2020

Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness

1 reference

12 December 2020

Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season

1 reference

12 December 2020

Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003.

1 reference

12 December 2020

1 reference

12 December 2020

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

1 reference

12 December 2020

Influenza. The role of burden-of-illness research

1 reference

12 December 2020

Vaccines for preventing influenza in healthy adults

1 reference

12 December 2020

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

12 December 2020

Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003

1 reference

12 December 2020

Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use.

1 reference

12 December 2020

1 reference

12 December 2020